Clinical trial

Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer

NCT00559429

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-12-01

PhasePHASE1

Study timeline

Study start (unknown)2004-12-01Date precision: month

Registry last updated2008-12-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

DocetaxelDRUG · verified · RxNorm: docetaxel

Sponsors & collaborators

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkinslead sponsor

Sanoficollaborator

Cytogen Corporationcollaborator

Mapped research locations

BaltimoreMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00559429 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.